Newsweek Names CancerIQ One of the Worlds Best Digital Health Companies
Summary
"Being recognized as one of the best digital health companies by Newsweek is yet another validation that our efforts are making an impact," said Feyi Ayodele, founder and CEO of CancerIQ. Being recognized as one of the best digital health companies by Newsweek is yet another validation that our efforts are making an impact," said Feyi Ayodele, founder and CEO of CancerIQ. CancerIQ is the only cancer-focused precision health platform that empowers healthcare providers to detect cancer earlier and prevent it altogether across all patient populations. Integrated directly into real-time EHR workflows, CancerIQ makes it easy to gather comprehensive patient data, automatically map it to the latest evidence-based guidelines, and expand access to personalized care plans, cutting-edge clinical solutions, and genomic innovations. CancerIQ co-founder and CEO Feyi Ayodele was recently named a Modern Healthcare Innovator for pioneering this transformative approach to cancer prevention, early detection and treatment.